immuglo

Immuglo is a brand of **human normal immunoglobulin** (IVIG) used as a replacement therapy for individuals with primary or secondary immunodeficiency states where antibody-forming capacity is severely impaired. It is a purified preparation of immunoglobulin G (IgG) pooled from the plasma of healthy donors. Immuglo acts by providing passive immunity, supplying essential antibodies that the patient’s own immune system cannot produce adequately. The therapy strengthens the body’s natural immune system, reducing the risk of infections, particularly for those undergoing bone marrow transplantation or suffering from primary immunoglobulin deficiencies. Mechanistically, IVIG works by interacting with multiple immune components, including cytokines, complement, and Fc receptors, neutralizing pathogens and modulating immune function. Immuglo is administered intravenously and is also indicated for some autoimmune conditions as immunomodulatory therapy[1][3][5][7].

Brand names

Immuglo

Other names

Immuglo 5% InjectionImmuglo 5gm InjectionImmuglo5gm InjectionImmuglo-5gm Injection